Literature DB >> 35917343

Treatment of ovarian cancer with modified anthrax toxin.

Klaus Aktories1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35917343      PMCID： PMC9371659          DOI： 10.1073/pnas.2210179119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   12.779


× No keyword cloud information.
  15 in total

Review 1.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

Review 2.  Anthrax toxin: receptor binding, internalization, pore formation, and translocation.

Authors:  John A T Young; R John Collier
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

Review 3.  Epithelial ovarian cancer.

Authors:  Stephanie Lheureux; Charlie Gourley; Ignace Vergote; Amit M Oza
Journal:  Lancet       Date:  2019-03-23       Impact factor: 79.321

4.  Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.

Authors:  N S Duesbery; C P Webb; S H Leppla; V M Gordon; K R Klimpel; T D Copeland; N G Ahn; M K Oskarsson; K Fukasawa; K D Paull; G F Vande Woude
Journal:  Science       Date:  1998-05-01       Impact factor: 47.728

Review 5.  Anthrax, MEK and cancer.

Authors:  J F Bodart; A Chopra; X Liang; N Duesbery
Journal:  Cell Cycle       Date:  2002-01       Impact factor: 4.534

Review 6.  Membrane-Anchored Serine Proteases and Protease-Activated Receptor-2-Mediated Signaling: Co-Conspirators in Cancer Progression.

Authors:  Nisha R Pawar; Marguerite S Buzza; Toni M Antalis
Journal:  Cancer Res       Date:  2019-01-04       Impact factor: 12.701

7.  Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage.

Authors:  R Leduc; S S Molloy; B A Thorne; G Thomas
Journal:  J Biol Chem       Date:  1992-07-15       Impact factor: 5.157

Review 8.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

9.  Immunotoxins: From Design to Clinical Application.

Authors:  Robert J Kreitman; Ira Pastan
Journal:  Biomolecules       Date:  2021-11-15

Review 10.  Tumor Targeting and Drug Delivery by Anthrax Toxin.

Authors:  Christopher Bachran; Stephen H Leppla
Journal:  Toxins (Basel)       Date:  2016-07-01       Impact factor: 4.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.